Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia
- PMID: 20663204
 - PMCID: PMC2923121
 - DOI: 10.1186/1471-2350-11-115
 
Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia
Abstract
Background: Mutations in the LDLR gene are the most frequent cause of Familial hypercholesterolemia, an autosomal dominant disease characterised by elevated concentrations of LDL in blood plasma. In many populations, large genomic rearrangements account for approximately 10% of mutations in the LDLR gene.
Methods: DNA diagnostics of large genomic rearrangements was based on Multiple Ligation dependent Probe Amplification (MLPA). Subsequent analyses of deletion and duplication breakpoints were performed using long-range PCR, PCR, and DNA sequencing.
Results: In set of 1441 unrelated FH patients, large genomic rearrangements were found in 37 probands. Eight different types of rearrangements were detected, from them 6 types were novel, not described so far. In all rearrangements, we characterized their exact extent and breakpoint sequences.
Conclusions: Sequence analysis of deletion and duplication breakpoints indicates that intrachromatid non-allelic homologous recombination (NAHR) between Alu elements is involved in 6 events, while a non-homologous end joining (NHEJ) is implicated in 2 rearrangements. Our study thus describes for the first time NHEJ as a mechanism involved in genomic rearrangements in the LDLR gene.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- Goldstein JL, Hobbs HH, Brown MS. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Baudet AL, Sly WS, Valle D, editor. New York: McGraw-Hill Medical Publishing Division; 2001. Familial hypercholesterolemia; pp. 2863–2910.
 
 - 
    
- Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29(21):2625–2633. doi: 10.1093/eurheartj/ehn422. - DOI - PMC - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
